MBX Biosciences (MBX) Current Leases (2023 - 2026)
MBX Biosciences (MBX) reported Current Leases of $178000.0 for Q1 2026, up 36.92% on a YoY basis from $130000.0 in Q1 2025, and up 3.49% sequentially from $172000.0 in Q4 2025.
MBX Biosciences (MBX) Current Leases (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Current Leases data on file, last reported at $178000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 36.92% year-over-year to $178000.0; the trailing twelve-month figure through Mar 2026 stood at $178000.0 (up 36.92% YoY), and the FY2025 full-year result was $172000.0, up 0.58% from the prior year.
- Current Leases rose to $178000.0 in Q1 2026, from $172000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $178000.0 in Q1 2026 to a low of $130000.0 in Q1 2025.
- A 4-year average of $157750.0 and a median of $160000.0 in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases dropped 7.23% in 2025 and jumped 36.92% in 2026, its largest moves.
- Tracing MBX's Current Leases over 4 years: stood at $153000.0 in 2023, then gained by 11.76% to $171000.0 in 2024, then gained by 0.58% to $172000.0 in 2025, then advanced by 3.49% to $178000.0 in 2026.
- Business Quant data shows MBX's Current Leases at $178000.0 in Q1 2026, $172000.0 in Q4 2025, and $154000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | 178,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 178,000.00 |
| Dec 31, 2025 | 172,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Dec 31, 2023 | 153,000.00 |